Unique Ingredient Identifier LQA7B6G8JG is listed as a ingredient substance
| RN | 691397-13-4 |
| NCIT | C80936 |
| RXCUI | 155152 |
| MF | Polymer substance not supported |
UNII LQA7B6G8JG POLOXAMER 188 is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| INTRAMUSCULAR | POWDER, FOR INJECTION SUSPENSION | 0.2 %W/V |
| INTRAVENOUS | INJECTION | 0.6 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 0.22 % |
| OPHTHALMIC | SOLUTION | 0.1 % |
| ORAL | CAPSULE | 25.1 mg |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN | 3.18 MG |
| ORAL | CAPSULE, DELAYED ACTION | 4 MG |
| ORAL | CAPSULE, DELAYED RELEASE | 3 MG |
| ORAL | CONCENTRATE | 0.25 MG/1ML |
| ORAL | GRANULE | NA |
| ORAL | GRANULE, FOR ORAL SOLUTION | 26 MG |
| ORAL | LIQUID,EXTENDED RELEASE | 0.5 MG/ML |
| ORAL | POWDER, FOR ORAL SOLUTION | 25 MG |
| ORAL | POWDER, FOR ORAL SUSPENSION | 17 MG/5ML |
| ORAL | POWDER, FOR SOLUTION | 25 MG/5ML |
| ORAL | SOLUTION | 100 MG/1ML |
| ORAL | SUSPENSION | 25 MG/5ML |
| ORAL | SUSPENSION | 3.5 mg/1mL |
| ORAL | SYRUP | NA |
| ORAL | TABLET | 66.9 MG |
| ORAL | TABLET, COATED | 3 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 5.61 MG |
| ORAL | TABLET, DELAYED ACTION | 3 MG |
| ORAL | TABLET, EXTENDED RELEASE | 37 MG |
| ORAL | TABLET, FILM COATED | NA |
| PERIODONTAL | GEL | 5.5 % |
| SUBCUTANEOUS | INJECTION | 0.3 % |
| SUBCUTANEOUS | SOLUTION, INJECTION | 0.2 % |
| TOPICAL | EMULSION, CREAM | 1 %W/W |